Delivery Order SPE2DB22D1106-SPE2DB25FEMB9
Award Date
5/6/25
Potential Completion Date
5/7/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,222.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,955,862 units of the medication Ondansetron ODT 8 mg Tablet, with an ultimate completion date of April 18, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, valued at $37,982.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,568,178,340 units of the medication Ondansetron ODT 8 mg tablets, with a completion date of May 8, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $48,550.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4,568,143,838 units of the medication Ondansetron ODT 8 mg Tablet, with a performance period ending on May 6, 2025. The contract is a firm fixed-price arrangement and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $27,519.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,060,760 units of the medication Ondansetron ODT 8 mg tablet, with a performance period ending on April 29, 2025. This contract is a delivery order and is priced on a firm-fixed-price basis. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award, valued at $2,283.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,202,191 units of the medication Ondansetron HCL 8 mg Tablet, with an ultimate completion date of May 12, 2025. The contract is a delivery order and is priced on a firm fixed-price basis. It is not designated as a set-aside contract, indicating open...
This federal contract award is a delivery order valued at $2,283.84, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,568,093,080 units of the pharmaceutical drug Ondansetron HCL 8 mg tablets. The contract has a firm fixed price and an ultimate completion date of May 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,652,155 units of Ondansetron HCL 8 mg tablets. The firm-fixed-price delivery order, valued at $3,711.94, has a period of performance through November 1, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $48,748.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,563,250,472 units of the drug Ondansetron ODT 4 mg tablet, with a performance period through January 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award, valued at $2,068.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,598,427 units of the medication Ondansetron ODT 8 mg Tablet, with a completion date of December 4, 2024. The contract is structured as a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor,...
This federal contract award, valued at $12,914.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,718,108 units of Ondansetron HCL 4 mg tablets in 30-count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of December 16, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...